Pharmaceutically active compounds degradation using doped TiO2 functionalized zeolite photocatalyst

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was the investigation of photocatalytic degradation of pharmaceutically active compounds using doped TiO2 functionalized zeolite photocatalyst. Diclofenac (DCF), a non-steroidal antiinflammatory drug, that represents a biorefractory micropollutant, was chosen as model of pharmaceutically active compound. The photocatalyst was Z-TiO2-Ag. The concentration of DCF in the working solutions was 10 mg/L,50 mg/L,100 mg/L and 200 mg/L and of photocatalyst 1 g/L in any experiments. The process was monitored by recording the UV spectra of the treated solutions and total organic carbon (TOC) determination. The UV spectra analysis and TOC removal proved that along the advanced degradation of DCF also a mineralization process occurred. The carried out research provided useful information envisaging the treatment of pharmaceutical effluents by photocatalysis.

Cite

CITATION STYLE

APA

Ihos, M., Bogatu, C., Lazau, C., Manea, F., & Pode, R. (2018). Pharmaceutically active compounds degradation using doped TiO2 functionalized zeolite photocatalyst. Revista de Chimie, 69(1), 34–37. https://doi.org/10.37358/rc.18.1.6040

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free